-

U.S. Paid Social Forecast Report H1 2025: Spending Remains Resilient Despite Uncertainty and Changes Across Landscape - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "U.S. Paid Social Forecast Report H1 2025: Spending Remains Resilient Despite Uncertainty and Changes Across Landscape" report has been added to ResearchAndMarkets.com's offering.

U.S. ad spend on social networks is expected to increase in 2025 despite tariffs and other challenges facing the sector. Investments in AI, social commerce, the continued rise of influencer marketing, and several other factors will fuel growth.

How will ad spending across social networks change in 2025?

Key Stat: Tariffs could reduce the forecast for US social network ad spending by up to 10% this year, but the market would still increase under that scenario.

For more information about this report visit https://www.researchandmarkets.com/r/1o8x42

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Industry:

Research and Markets

Release Versions
English

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Vaccine Collaboration and Licensing Agreements Analysis Report 2025 with Directory of 818 Deals - Upfront, Milestone, Royalties Financial Terms, Company A-Z, Deal Type and Therapy Area - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Vaccine Collaboration and Licensing Deals 2016-2025" report has been added to ResearchAndMarkets.com's offering. This report contains a comprehensive listing of 818 vaccine deals announced since 2016 including financial terms where available including links to online deal records of actual vaccine partnering deals as disclosed by the deal parties. Fully revised and updated, the report provides details of vaccine deals from 2016 to 2025. Vaccine Collaboration and Li...

Enterprise Workforce Management Market Analysis Report 2025 Featuring Aspect, Assembled, Bright Pattern, Calabrio, NICE, and Verint Systems - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "2025 Workforce Management for the Enterprise" report has been added to ResearchAndMarkets.com's offering. This report provides an in-depth analysis of this mature yet evolving market whose continued projected growth is attributable to factors such as increasing adoption of cloud-based solutions, growing demand for remote work management, and the need for productivity improvements and operational efficiency across verticals. A reawakening and transforming sector It'...

$96.17 Bn In-vitro Diagnostics (IVD) Reagents Market - Global Outlook & Forecasts 2025-2030 Featuring Prominent Players - Abbott, Danaher, F. Hoffmann-La Roche, Siemens, and Thermo Fisher Scientific - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "In-vitro Diagnostics (IVD) Reagents Market - Global Outlook & Forecast 2025-2030" report has been added to ResearchAndMarkets.com's offering. The In-vitro Diagnostics (IVD) Reagents Market was valued at USD 77.56 Billion in 2024, and is projected to reach USD 96.17 Billion by 2030, rising at a CAGR of 3.65% The report considers the present scenario of the global IVD reagents market and its market dynamics for 2025-2030. It covers a detailed overview of several...
Back to Newsroom